Page last updated: 2024-08-16

ribavirin and ubiquinone

ribavirin has been researched along with ubiquinone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
David, D; Garcia, C; Guarda, DC; Rubin, J; Rupprecht, CE; Stamler, A; Willoughby, RE; Zohar, Z1
Frampton, CM; Gane, EJ; Gibson, M; Keogh, GF; Lockhart, MM; Murphy, MP; Orr, DW; Smith, RA; Taylor, KM; Weilert, F1

Trials

1 trial(s) available for ribavirin and ubiquinone

ArticleYear
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:7

    Topics: Administration, Oral; Adult; Alanine Transaminase; Antioxidants; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Double-Blind Method; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Mitochondria, Liver; Organophosphorus Compounds; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Ubiquinone; Viral Load

2010

Other Studies

1 other study(ies) available for ribavirin and ubiquinone

ArticleYear
Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea.
    Scandinavian journal of infectious diseases, 2009, Volume: 41, Issue:5

    Topics: Amantadine; Anesthetics, Dissociative; Animals; Antiviral Agents; Child, Preschool; Combined Modality Therapy; Dogs; Drug Therapy, Combination; Equatorial Guinea; Fatal Outcome; Humans; Ketamine; Male; Midazolam; Rabies; Rabies virus; Ribavirin; Treatment Outcome; Ubiquinone

2009